Sign in
4

Changes in Ownership

Trevi Therapeutics, Inc. Filed Acc 0000950170-24-063531

President & CEO sold 25,037 shares at $2.86 ($71,576)

  • President & CEO acquired 25,037 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

GOOD JENNIFER L · President & CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-05-20 Exercise or conversion : show line 1 in the form +25,037 $2.19 $54,831 238,350 D
2024-05-20 Sale : show line 2 in the form −25,037 $2.86 $71,576 213,313 D
Open-market sales · 25,037 sh · avg $2.86 · $71,576

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-05-20 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −25,037 33,189 D
Loading xslF345X05/ownership.xml…